Island Pharmaceuticals Limited (ASX:ILA)
Australia · Delayed Price · Currency is AUD 0.4900
+0.0050 (1.03%)
At close: Mar 11, 2026
Island Pharmaceuticals Market Cap
Island Pharmaceuticals has a market cap or net worth of 142.96 million as of March 11, 2026. Its market cap has increased by 458.51% in one year.
Market Cap
142.96M
Enterprise Value
136.09M
Revenue
62.85K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.49
Market Cap Chart
Since April 13, 2021, Island Pharmaceuticals's market cap has increased from 42.51M to 142.96M, an increase of 236.31%. That is a compound annual growth rate of 28.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 144.44M | 24.84% |
| Dec 31, 2025 | 115.69M | 274.76% |
| Dec 31, 2024 | 30.87M | 299.86% |
| Dec 29, 2023 | 7.72M | -48.65% |
| Dec 28, 2022 | 15.03M | -27.45% |
| Dec 31, 2021 | 20.72M | -51.25% |
| Apr 13, 2021 | 42.51M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orthocell | 225.19M |
| Dimerix | 225.15M |
| Tetratherix | 203.06M |
| Starpharma Holdings | 167.97M |
| Actinogen Medical | 143.03M |
| Recce Pharmaceuticals | 125.79M |
| Botanix Pharmaceuticals | 122.00M |
| Paradigm Biopharmaceuticals | 114.21M |